Cite

HARVARD Citation

    Albiges, L. et al. (2021). Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program. European journal of cancer. pp. 102-111. [Online]. 
  
Back to record